# Sanger Human Cell Atlasing Project

> **NCT06497673** · — · ENROLLING_BY_INVITATION · sponsor: **The Wellcome Sanger Institute** · enrollment: 4000 (estimated)

## Conditions studied

- Human Development
- Genetic Disease

## Interventions

- **OTHER:** sample collection

## Key facts

- **NCT ID:** NCT06497673
- **Lead sponsor:** The Wellcome Sanger Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2019-12-16
- **Primary completion:** 2029-11-07
- **Final completion:** 2029-11-07
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06497673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06497673, "Sanger Human Cell Atlasing Project". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06497673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*